Patents by Inventor Daniel Rossignol

Daniel Rossignol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for immunotherapy
    Publication number: 20070292418
    Abstract: The invention relates to immunotherapeutic compounds, compositions that include such compounds, and methods of using the compounds, for example, to treat an individual having, at risk for, or previously treated for a cancer.
    Type: Application
    Filed: November 28, 2006
    Publication date: December 20, 2007
    Inventors: Scott Fields, Lynn Hawkins, Sally Ishizaka, Daniel Rossignol
  • Compositions and methods for cancer immunotherapy
    Publication number: 20070020232
    Abstract: The invention relates to immunotherapeutic compounds and to methods for stimulating an immune response in a subject individual at risk for developing cancer, diagnosed with a cancer, in treatment for cancer, or in post-therapy recovery from cancer or the compounds of the invention can be administered as a prophylactic to a subject individual to prevent or delay the development of cancer.
    Type: Application
    Filed: April 26, 2006
    Publication date: January 25, 2007
    Applicant: Eisai Co., Ltd.
    Inventors: Daniel Rossignol, Sally Ishizaka, Lynn Hawkins, Scott Fields
  • Methods for treating severe acute respiratory syndrome
    Publication number: 20060276431
    Abstract: The invention provides methods for treating severe acute respiratory syndrome (SARS) with lipopolysaccharides.
    Type: Application
    Filed: January 13, 2006
    Publication date: December 7, 2006
    Inventor: Daniel Rossignol
  • Methods and kits for use in the diagnosis and treatment of endotoxemia
    Publication number: 20060051821
    Abstract: The invention provides methods and kits for use in determining whether a patient may benefit from treatment with a toll-like receptor 4 (TLR4) antagonist, such as an antiendotoxin compound.
    Type: Application
    Filed: February 12, 2004
    Publication date: March 9, 2006
    Inventors: Daniel Rossignol, Melvyn Lynn
  • Use of an anti-endotoxin drug in the prevention and treatment of disease
    Publication number: 20050215517
    Abstract: The invention provides methods for preventing and treating disease involving the use of an anti-endotoxin drug.
    Type: Application
    Filed: December 13, 2004
    Publication date: September 29, 2005
    Inventors: Daniel Rossignol, Melvyn Lynn, William Kerns
  • Use of an anti-endotoxin drug in the prevention and treatment of disease
    Publication number: 20050153929
    Abstract: The invention provides methods for preventing and treating disease involving the use of an anti-endotoxin drug.
    Type: Application
    Filed: December 13, 2004
    Publication date: July 14, 2005
    Inventors: Daniel Rossignol, Melvyn Lynn, Clifford DiLea
  • Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
    Publication number: 20020042379
    Abstract: The invention provides methods for administering an anti-endotoxin drug, E5564, by bolus or intermittent intravenous infusion. The methods can be used for treating conditions such as endotoxemia, sepsis, and septic shock.
    Type: Application
    Filed: June 11, 2001
    Publication date: April 11, 2002
    Inventors: Daniel Rossignol, Melvyn Lynn, Clifford DiLea